-
2
-
-
0037100329
-
Human papillomavirus and the long-term risk of cervical neoplasia
-
van der Graaf Y, Molijn A, Doornewaard H, et al. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol. 2002;156:158-164.
-
(2002)
Am J Epidemiol
, vol.156
, pp. 158-164
-
-
van der Graaf, Y.1
Molijn, A.2
Doornewaard, H.3
-
3
-
-
0032840918
-
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
-
Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:1-3.
-
(1999)
J Pathol
, vol.189
, pp. 1-3
-
-
Walboomers, J.M.1
Jacobs, M.V.2
Manos, M.M.3
-
4
-
-
0032743399
-
Papillomaviruses in human cancers
-
zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians. 1999;111:581-587.
-
(1999)
Proc Assoc Am Physicians
, vol.111
, pp. 581-587
-
-
zur Hausen, H.1
-
5
-
-
0029041842
-
Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group
-
Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796-802.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 796-802
-
-
Bosch, F.X.1
Manos, M.M.2
Munoz, N.3
-
6
-
-
33745058668
-
Human papillomavirus-specific viral types are common in Mexican women affected by cervical lesions
-
Pina-Sanchez P, Hernandez-Hernandez D, Lopez-Romero R, et al. Human papillomavirus-specific viral types are common in Mexican women affected by cervical lesions. Int J Gynecol Cancer. 2006;16:1-7.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 1-7
-
-
Pina-Sanchez, P.1
Hernandez-Hernandez, D.2
Lopez-Romero, R.3
-
7
-
-
35948968716
-
Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix
-
Tong SY, Lee YS, Park JS, et al. Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix. Int J Gynecol Cancer. 2007;17:1307-1313.
-
(2007)
Int J Gynecol Cancer
, vol.17
, pp. 1307-1313
-
-
Tong, S.Y.1
Lee, Y.S.2
Park, J.S.3
-
8
-
-
0029759768
-
Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer
-
Burger RA, Monk BJ, Kurosaki T, et al. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst. 1996;88:1361-1368.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1361-1368
-
-
Burger, R.A.1
Monk, B.J.2
Kurosaki, T.3
-
9
-
-
0035300612
-
Human papillomavirus and prognosis of invasive cervical cancer: A population-based study
-
Schwartz SM, Daling JR, Shera KA, et al. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol. 2001;19:1906-1915.
-
(2001)
J Clin Oncol
, vol.19
, pp. 1906-1915
-
-
Schwartz, S.M.1
Daling, J.R.2
Shera, K.A.3
-
10
-
-
0031927311
-
Human papillomavirus genotype as a major determinant of the course of cervical cancer
-
Lombard I, Vincent-Salomon A, Validire P, et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol. 1998;16:2613-2619.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2613-2619
-
-
Lombard, I.1
Vincent-Salomon, A.2
Validire, P.3
-
11
-
-
0029002987
-
Associations between oncogenic human papillomaviruses and local invasive patterns in cervical cancer
-
Zhang J, Rose BR, Thompson CH, et al. Associations between oncogenic human papillomaviruses and local invasive patterns in cervical cancer. Gynecol Oncol. 1995;57:70-77.
-
(1995)
Gynecol Oncol
, vol.57
, pp. 70-77
-
-
Zhang, J.1
Rose, B.R.2
Thompson, C.H.3
-
12
-
-
0028840564
-
Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: A possible role for type 18
-
Rose BR, Thompson CH, Simpson JM, et al. Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: a possible role for type 18. Am J Obstet Gynecol. 1995;173: 1461-1468.
-
(1995)
Am J Obstet Gynecol
, vol.173
, pp. 1461-1468
-
-
Rose, B.R.1
Thompson, C.H.2
Simpson, J.M.3
-
13
-
-
0141455140
-
Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion
-
Im SS, Wilczynski SP, Burger RA, et al. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin Cancer Res. 2003;9: 4145-4150.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 4145-4150
-
-
Im, S.S.1
Wilczynski, S.P.2
Burger, R.A.3
-
14
-
-
0029756780
-
p. 53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene
-
Spitkovsky D, Aengeneyndt F, Braspenning J, et al. p. 53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Oncogene. 1996;13:1027-1035.
-
(1996)
Oncogene
, vol.13
, pp. 1027-1035
-
-
Spitkovsky, D.1
Aengeneyndt, F.2
Braspenning, J.3
-
15
-
-
0037325976
-
Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system
-
Scheffner M, Whitaker NJ. Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin Cancer Biol. 2003;13:59-67.
-
(2003)
Semin Cancer Biol
, vol.13
, pp. 59-67
-
-
Scheffner, M.1
Whitaker, N.J.2
-
16
-
-
0024292712
-
The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A
-
Phelps WC, Yee CL, Munger K, et al. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell. 1988;53:539-547.
-
(1988)
Cell
, vol.53
, pp. 539-547
-
-
Phelps, W.C.1
Yee, C.L.2
Munger, K.3
-
17
-
-
0030766214
-
Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter
-
He Y, Huang L. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter. Cancer Res. 1997;57:3993-3999.
-
(1997)
Cancer Res
, vol.57
, pp. 3993-3999
-
-
He, Y.1
Huang, L.2
-
18
-
-
0028823757
-
In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes
-
Tan TM, Ting RC. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Cancer Res. 1995;55: 4599-4605.
-
(1995)
Cancer Res
, vol.55
, pp. 4599-4605
-
-
Tan, T.M.1
Ting, R.C.2
-
19
-
-
34447629237
-
Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells
-
Sima N, Wang S, Wang W, et al. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Gynecol Oncol. 2007;106:299-304.
-
(2007)
Gynecol Oncol
, vol.106
, pp. 299-304
-
-
Sima, N.1
Wang, S.2
Wang, W.3
-
20
-
-
0029832231
-
In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug
-
Blagosklonny MV, el-Deiry WS. In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug. Int J Cancer. 1996;67:386-392.
-
(1996)
Int J Cancer
, vol.67
, pp. 386-392
-
-
Blagosklonny, M.V.1
el-Deiry, W.S.2
-
21
-
-
0141730323
-
siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells
-
Butz K, Ristriani T, Hengstermann A, et al. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene. 2003;22:5938-5945.
-
(2003)
Oncogene
, vol.22
, pp. 5938-5945
-
-
Butz, K.1
Ristriani, T.2
Hengstermann, A.3
-
22
-
-
3042723816
-
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia
-
Hallez S, Simon P, Maudoux F, et al. Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia. Cancer Immunol Immunother. 2004;53:642-650.
-
(2004)
Cancer Immunol Immunother
, vol.53
, pp. 642-650
-
-
Hallez, S.1
Simon, P.2
Maudoux, F.3
-
23
-
-
0035956215
-
The human papillomavirus E6 protein and its contribution to malignant progression
-
Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 2001;20: 7874-7887.
-
(2001)
Oncogene
, vol.20
, pp. 7874-7887
-
-
Mantovani, F.1
Banks, L.2
-
24
-
-
0031465731
-
p21/p53, cellular growth control and genomic integrity
-
el-Deiry WS. p21/p53, cellular growth control and genomic integrity. Curr Top Microbiol Immunol. 1998;227:121-137.
-
(1998)
Curr Top Microbiol Immunol
, vol.227
, pp. 121-137
-
-
el-Deiry, W.S.1
-
25
-
-
0033018458
-
New concepts on the role of human papillomavirus in cell cycle regulation
-
Syrjänen SM, Syrjänen KJ. New concepts on the role of human papillomavirus in cell cycle regulation. Ann Med. 1999;31:175-187.
-
(1999)
Ann Med
, vol.31
, pp. 175-187
-
-
Syrjänen, S.M.1
Syrjänen, K.J.2
-
26
-
-
0033818848
-
Disruptions of cell cycle control by human papillomaviruses with special reference to cervical carcinoma
-
Southern SA, Herrington CS. Disruptions of cell cycle control by human papillomaviruses with special reference to cervical carcinoma. Int J Gynecol Cancer. 2000;10:263-274.
-
(2000)
Int J Gynecol Cancer
, vol.10
, pp. 263-274
-
-
Southern, S.A.1
Herrington, C.S.2
-
27
-
-
0027292297
-
Cyclin G: A new mammalian cyclin with homology to fission yeast Cig
-
Tamura K, Kanaoka Y, Jinno S, et al. Cyclin G: a new mammalian cyclin with homology to fission yeast Cig. Oncogene. 1993;8:2113-2118.
-
(1993)
Oncogene
, vol.8
, pp. 2113-2118
-
-
Tamura, K.1
Kanaoka, Y.2
Jinno, S.3
-
28
-
-
0034978891
-
Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery
-
Kimura SH, Ikawa M, Ito A, et al. Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery. Oncogene. 2001;20:3290-3300.
-
(2001)
Oncogene
, vol.20
, pp. 3290-3300
-
-
Kimura, S.H.1
Ikawa, M.2
Ito, A.3
-
29
-
-
0037226847
-
Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways
-
Zhao L, Samuels T, Winckler S, et al. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Mol Cancer Res. 2003;1:195-206.
-
(2003)
Mol Cancer Res
, vol.1
, pp. 195-206
-
-
Zhao, L.1
Samuels, T.2
Winckler, S.3
-
32
-
-
0033815828
-
IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation
-
Hollowood AD, Lai T, Perks CM, et al. IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. Int J Cancer. 2000;88:336-341.
-
(2000)
Int J Cancer
, vol.88
, pp. 336-341
-
-
Hollowood, A.D.1
Lai, T.2
Perks, C.M.3
-
33
-
-
14744275857
-
The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase
-
Kelley ML, Keiger KE, Lee CJ, et al. The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase. J Virol. 2005;9:3737-3747.
-
(2005)
J Virol
, vol.9
, pp. 3737-3747
-
-
Kelley, M.L.1
Keiger, K.E.2
Lee, C.J.3
-
34
-
-
0042674162
-
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme
-
Okamoto Y, Ozaki T, Miyazaki K, et al. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res. 2003;63:4167-4173.
-
(2003)
Cancer Res
, vol.63
, pp. 4167-4173
-
-
Okamoto, Y.1
Ozaki, T.2
Miyazaki, K.3
-
35
-
-
0141568874
-
Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6
-
Duffy CL, Phillips SL, Klingelhutz AJ. Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6. Virology. 2003;314:196-205.
-
(2003)
Virology
, vol.314
, pp. 196-205
-
-
Duffy, C.L.1
Phillips, S.L.2
Klingelhutz, A.J.3
-
36
-
-
0033998608
-
Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31
-
Chang YE, Laimins LA. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J Virol. 2000;74:4174-4182.
-
(2000)
J Virol
, vol.74
, pp. 4174-4182
-
-
Chang, Y.E.1
Laimins, L.A.2
-
37
-
-
0037081132
-
Quantitative reverse transcription-polymerase chain reaction (TR-PCR): A comparison of prime-dropping, competitive, and real-time RT-PCRs
-
Wall SJ, Edward DR. Quantitative reverse transcription-polymerase chain reaction (TR-PCR): A comparison of prime-dropping, competitive, and real-time RT-PCRs. Anal Biochem. 2002;300:269-273.
-
(2002)
Anal Biochem
, vol.300
, pp. 269-273
-
-
Wall, S.J.1
Edward, D.R.2
|